Articles with public access mandates - Gábor HalmosLearn more
Not available anywhere: 6
Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth
M Zarandi, R Cai, M Kovacs, P Popovics, L Szalontay, T Cui, W Sha, ...
Peptides 89, 60-70, 2017
Mandates: US Department of Veterans Affairs, Helmholtz Association
Comparative in vitro biological evaluation of daunorubicin containing GnRH‐I and GnRH‐II conjugates developed for tumor targeting
I Szabó, S Bősze, E Orbán, É Sipos, G Halmos, M Kovács, G Mező
Journal of Peptide Science 21 (5), 426-435, 2015
Mandates: Hungarian Scientific Research Fund
Targeting to peptide receptors
AV Schally, G Halmos
Drug Delivery in Oncology: From Basic Research to Cancer Therapy, 1219-1261, 2011
Mandates: Hungarian Scientific Research Fund
Signaling mechanism of growth hormone-releasing hormone receptor
G Halmos, Z Szabo, E Juhasz, AV Schally
Vitamins and hormones 123, 1-26, 2023
Mandates: US Department of Veterans Affairs
Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152)
G Oláh, N Dobos, G Vámosi, Z Szabó, É Sipos, K Fodor, K Harda, ...
European journal of pharmaceutical sciences 123, 371-376, 2018
Mandates: Hungarian Scientific Research Fund
Hypothalamic Releasing Hormones
G Halmos, N Dobos, E Juhasz, Z Szabo, AV Schally
Hormonal Signaling in Biology and Medicine, 43-68, 2020
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Available somewhere: 30
The role of indoleamine-2, 3-dioxygenase in cancer development, diagnostics, and therapy
L Hornyák, N Dobos, G Koncz, Z Karányi, D Páll, Z Szabó, G Halmos, ...
Frontiers in immunology 9, 151, 2018
Mandates: Hungarian Academy of Sciences, National Office for Research, Development and …
RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases
L Halász, Z Karányi, B Boros-Oláh, T Kuik-Rózsa, É Sipos, É Nagy, ...
Genome research 27 (6), 1063-1073, 2017
Mandates: National Institute of Health and Medical Research, France, Hungarian Academy …
Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities
R Cai, AV Schally, T Cui, L Szalontay, G Halmos, W Sha, M Kovacs, ...
Peptides 52, 104-112, 2014
Mandates: US National Institutes of Health
Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin–GnRH-III bioconjugates
R Hegedüs, M Manea, E Orbán, I Szabó, É Kiss, É Sipos, G Halmos, ...
European journal of medicinal chemistry 56, 155-165, 2012
Mandates: Hungarian Scientific Research Fund
Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 (AEZS-108)
K Szepeshazi, AV Schally, G Keller, NL Block, D Benten, G Halmos, ...
Oncotarget 3 (7), 686, 2012
Mandates: Hungarian Scientific Research Fund
Novel antagonists of growth hormone‐releasing hormone inhibit growth and vascularization of human experimental ovarian cancers
A Klukovits, AV Schally, L Szalontay, I Vidaurre, A Papadia, M Zarandi, ...
Cancer 118 (3), 670-680, 2012
Mandates: Hungarian Scientific Research Fund
Drugging the R-loop interactome: RNA-DNA hybrid binding proteins as targets for cancer therapy
B Boros-Oláh, N Dobos, L Hornyák, Z Szabó, Z Karányi, G Halmos, ...
DNA repair 84, 102642, 2019
Mandates: Hungarian Academy of Sciences, National Office for Research, Development and …
Efficient synthesis of an (aminooxy) acetylated‐somatostatin derivative using (aminooxy) acetic acid as a ‘carbonyl capture’reagent
G Mezö, I Szabó, I Kertesz, R Hegedüs, E Orbán, U Leurs, S Bösze, ...
Journal of Peptide Science 17 (1), 39-46, 2011
Mandates: Hungarian Scientific Research Fund
Enhanced in vitro antitumor activity of GnRH-III-daunorubicin bioconjugates influenced by sequence modification
S Schuster, B Biri-Kovács, B Szeder, L Buday, J Gardi, Z Szabó, ...
Pharmaceutics 10 (4), 223, 2018
Mandates: European Commission, National Office for Research, Development and …
Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
S Schuster, B Biri-Kovács, B Szeder, V Farkas, L Buday, Z Szabó, ...
Beilstein Journal of Organic Chemistry 14 (1), 756-771, 2018
Mandates: Hungarian Scientific Research Fund, European Commission, National Office for …
Powerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108
K Szepeshazi, AV Schally, NL Block, G Halmos, M Nadji, L Szalontay, ...
Oncotarget 4 (5), 751, 2013
Mandates: Hungarian Scientific Research Fund
Receptors for luteinizing hormone‐releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelix
B Rozsa, M Nadji, AV Schally, B Dezso, T Flasko, G Toth, M Mile, ...
The Prostate 71 (5), 445-452, 2011
Mandates: Hungarian Scientific Research Fund
Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity
R Cai, X Zhang, H Wang, T Cui, G Halmos, W Sha, J He, P Popovics, ...
Peptides 150, 170716, 2022
Mandates: US Department of Veterans Affairs
Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma
A Treszl, Z Steiber, AV Schally, NL Block, B Dezso, G Olah, B Rozsa, ...
Oncotarget 4 (10), 1721, 2013
Mandates: Hungarian Scientific Research Fund
Publication and funding information is determined automatically by a computer program